Search Results - Rui-Feng Xu
- Showing 1 - 7 results of 7
-
1
-
2
-
3
Pathogenic microorganism DNA high-throughput genetic sequencing to diagnose peritoneal dialysis-associated peritonitis due to Mycobacterium tuberculosis infection by Rui-feng Xu, Wu-niri Gao, Ta-la Hu, Xi-feng Wang, Jian-rong Zhao, Yan Meng
Published in BMC Nephrology (2024-09-01)Get full text
Article -
4
Biomechanical and histomorphological analysis of the mandible in rats with chronic kidney disease by Ta-la Hu, Jun Chen, Shen-quan Shao, Le-le Li, Can Lai, Wu-niri Gao, Rui-feng Xu, Yan Meng
Published in Scientific Reports (2023-12-01)Get full text
Article -
5
Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database by Xi-Feng Wang, Lu-Ri Bao, Ta-La Hu, Rui-Feng Xu, Wu-Niri Gao, Jing-Yuan Wang, Jian-Rong Zhao, Zhen-Li Fu, Shu-Fang Wang, Yan Meng
Published in Frontiers in Pharmacology (2025-01-01)Get full text
Article -
6
Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database by Xi-Feng Wang, Lu-Ri Bao, Ta-La Hu, Rui-Feng Xu, Wu-Niri Gao, Jing-Yuan Wang, Jian-Rong Zhao, Zhen-Li Fu, Shu-Fang Wang, Yan Meng
Published in Frontiers in Pharmacology (2025-02-01)Get full text
Article -
7
ERBB2 is a potential diagnostic and prognostic biomarker in renal clear cell carcinoma by Wu-niri Gao, Li-gang Chen, Lu-ri Bao, Ning He, Ta-la Hu, Can Lai, Rui-feng Xu, Xi-feng Wang, Jing-yuan Wang, Jian-rong Zhao, Yan Meng
Published in Scientific Reports (2024-10-01)Get full text
Article
